Latest News- Carrier Screening Market: Expanded is expected to lead the Type segment during 2025-2029

The Carrier Screening Market is being driven by Rising prevalence of genetic diseases and disorders

The Carrier Screening Market is expected to grow at a CAGR of 22.5% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 3897.9 million. The Human Genome Project and the emergence of next-generation sequencing (NGS) technologies have revolutionized the carrier screening market by providing businesses with a comprehensive resource for mapping the entire human genome and deciphering genetic functionalities and structures. NGS has significantly advanced genetic research, enabling large-scale human genome sequencing to identify mutations and gene variants responsible for various diseases and disorders. Furthermore, NGS has drastically reduced the cost of sequencing, genomic analysis, and genomic database management, leading to a paradigm shift in the carrier screening industry. These advancements have empowered medical researchers to gain valuable insights into the genetic variations underlying genomic disorders. 

Get more information on Carrier Screening Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Type
  • Expanded
  • Targeted disease
• Technology
  • DNA sequencing
  • Polymerase chain reaction (PCR)
  • Microarrays
  • Others
• Test
  • Molecular screening tests
  • Biochemical screening tests
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Rising prevalence of genetic diseases and disorders
• Increasing prevalence of fetal chromosomal abnormalities
• Rising consciousness among masses regarding benefits of early detection and diagnosis of diseases

However, the market also witnesses some limitations, which are as follows:

• Varying regulations on carrier screening and research globally
• High cost associated with carrier screening
• Lack of trained genetic professionals

Benefits of Buying Global Carrier Screening Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Carrier Screening Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Carrier Screening Market is experiencing significant growth due to advancements in technologies such as Next-Generation Sequencing (NGS) and Targeted Sequencing. These innovations enable more accurate Variant Interpretation and offer Clinical Decision Support through Healthcare IT and Data Management. Mobile Health (mHealth), Artificial Intelligence (AI), Machine Learning (ML), Predictive Analytics, and Risk Modeling are also transforming the industry. Personalized and Precision Medicine applications extend to Reproductive Health, Family Planning, Preconception Counseling, and Reproductive Technologies for Genetic Disease Prevention. Public Health, Health Equity, Access to Care, Reimbursement Policies, Quality Control, Quality Assurance, Professional Development, and Clinical Trials are crucial aspects being addressed to ensure market progression.

Market Research Overview

The Carrier Screening market is a significant segment of the global Life Science Tools and Services industry. This market encompasses carrier screening tests, prenatal screening, genetic counseling, genetic testing, DNA sequencing, and chromosomal microarray analysis. The parent market, Life Science Tools and Services, covers R&D products and companies specializing in capital equipment, instruments, accessories, and consumables for pharmaceuticals and biotechnology, as well as laboratory diagnosis services. According to Technavio, the expansion of this market is primarily driven by the increasing global population aging, leading to a higher demand for healthcare and diagnostic services. The growth in the market is also fueled by advancements in genetic testing technologies and the rising awareness of genetic disorders. The global healthcare market size is calculated based on the combined revenues of equipment, supplies, pharmaceuticals, biotechnology, and life science tools and services manufacturers.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/